• Subscribe
  • About us
  • Advertise with us

NeuroSens

Menu

Skip to content
  • Home
  • Neurology
  • Psychiatry

Topic: MS

sNfL useful in prognosis for first demyelinating event

February 20, 2025  

Switching from natalizumab to anti-CD20 agents

January 28, 2025  

Fluid biomarkers during B cell-depleting therapy

January 17, 2025  

High-efficacy DMTs in MS – the year in review

November 14, 2024  

Pregnancy and MS – new data from ECTRIMS

October 17, 2024  

ECTRIMS update on ofatumumab

October 11, 2024  

ECTRIMS 2024 HIGHLIGHTS – FRIDAY, SEPTEMBER 20, 2024

September 20, 2024  

ECTRIMS 2024 HIGHLIGHTS – THURSDAY, SEPTEMBER 19, 2024

September 19, 2024  

ECTRIMS 2024 HIGHLIGHTS – WEDNESDAY, SEPTEMBER 18, 2024

September 18, 2024  

Does MS burn out?

August 20, 2024  
Previous
1
2
3
4
5
Next

Browse by Topic

  • CLINICAL CASES IN MS (17)
  • MS (418)
  • EAN 2025 (2)
  • BIOMARKERS IN MS (56)
  • EPILEPSY (36)
  • AAN 2025 (5)
  • ACTRIMS 2025 (6)
  • Library (17)
  • AES 2024 (1)
  • ECTRIMS 2024 (6)
  • EAN 2024 (3)
  • AD (85)
  • AAN 2024 (5)
  • ACTRIMS Forum 2024 (2)
  • PD (77)
  • COVID-19 (58)
  • MIGRAINE (25)
  • DEPRESSION (36)
  • STROKE (22)
  • SCHIZOPHRENIA (25)
  • DEMENTIA (10)
  • SLEEP (2)
  • PAIN (3)
  • BPD (4)
  • ALS (1)

Popular Posts

  • CLINICAL CASES IN MS: A PATIENT WITH MRI LESIONS CONSISTENT WITH MS posted on June 27, 2025
  • CLINICAL CASES IN MS: A 42 Y.O. WOMAN WITH A SEVERE RELAPSE ON DMF posted on June 26, 2025
  • EAN HIGHLIGHTS – TUESDAY, JUNE 24, 2025 posted on June 24, 2025
Copyright 2025 Lind Publishing Inc All rights reserved. Developed by Integration New Media, INC. (INM)
Contact Us Terms and Conditions